Atlas Trials

Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination

Clinical trial NCT06103994 · COMPLETED

Trial details

NCT number
NCT06103994
Sponsor
The Archer-Daniels-Midland Company
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Influenza
Start date
2023-10-27
Primary completion
2024-01-12
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.